GTC Biotherapeutics (fka GTCB)

[OKY]

"...it is my understanding this study is a dosing range study, and is not set up for efficacy results."

I would like to know what you mean. Before you study the
useful does range you need to establish efficacy. You can
do them both at the same time.

GTC with partner Leo are looking forward to being proven effective in DIC sepsis cases. This would be a life saving 1-2 billion dollar drug, well in some people’s estimation.

GTC also has a deal with Merrimack who is in trials
with a malaria drug. In that case Merrimack would create
the drug and pay royalties to GTC for the process.
If it works out, I don't know what thats worth.

http://www.gtc-bio.com/pressreleases/pr050504.html

In any case, we are looking two years down the pike. No
quick buck here as ATryn, even with off-label use, can't
bring GTC to profitability without additional approvals.